Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SULZER MEDICA ENTERING SPINAL SURGERY MARKET VIA SPINE-TECH ACQUISITION; $595 MIL. CASH TENDER OFFER IS ROUGHLY TEN TIMES BAK DEVELOPER's ANNUAL SALES VOLUME

This article was originally published in The Gray Sheet

Executive Summary

Sulzer Medica is paying a substantial premium to enter a high-growth segment of the orthopedics product market -- spinal surgery -- with the $595 mil. acquisition of Spine-Tech. The $52 per share tender offer, announced Dec. 16 and approved by the boards of both companies, represents a 14.3% premium to Spine-Tech's Dec. 15 closing price of 45-1/2.

You may also be interested in...



Split Rock Prepped To Invest In Medical Device Realm After Financing

Split Rock Partners expects to invest the majority of the $275 mil. it has raised from institutional investors into medical device start-up companies, according to Managing Director Dave Stassen

Split Rock Prepped To Invest In Medical Device Realm After Financing

Split Rock Partners expects to invest the majority of the $275 mil. it has raised from institutional investors into medical device start-up companies, according to Managing Director Dave Stassen

Reimbursement, Sales Critical For IPOs As Markets Reopen To Device Firms

"Reimbursement clarity" is essential for device firms in gaining investor confidence in the public equity market, Jeffrey Hoffman, health technology investment banker with U.S. Bancorp Piper Jaffray, emphasized at the recent Frost & Sullivan 5th Annual Medical Devices and Diagnostics Industry Conference in San Francisco.

Related Content

UsernamePublicRestriction

Register

MT009326

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel